180 related articles for article (PubMed ID: 18049170)
1. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
[TBL] [Abstract][Full Text] [Related]
2. Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.
Earle CC; Weiser MR; Ter Veer A; Skibber JM; Wilson J; Rajput A; Wong YN; Benson AB; Shibata S; Romanus D; Niland J; Schrag D
J Surg Oncol; 2009 Dec; 100(7):525-8. PubMed ID: 19697351
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.
Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J
Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591
[TBL] [Abstract][Full Text] [Related]
4. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
5. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
8. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.
Bouchardy C; Queneau PE; Fioretta G; Usel M; Zellweger M; Neyroud I; Raymond L; de Wolf C; Sappino AP
Br J Cancer; 2001 Nov; 85(9):1251-7. PubMed ID: 11720457
[TBL] [Abstract][Full Text] [Related]
10. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
11. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
12. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
Gertler R; Rosenberg R; Schuster T; Friess H
Eur J Cancer; 2009 Nov; 45(17):2992-9. PubMed ID: 19682890
[TBL] [Abstract][Full Text] [Related]
13. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
14. [Adjuvant chemotherapy for colon adenocarcinoma in the county of Côte-d'Or].
Jouve JL; Mitry E; Phelip JM; Villing AL; Tazi MA; Faivre J
Gastroenterol Clin Biol; 1998 Mar; 22(3):269-72. PubMed ID: 9762209
[TBL] [Abstract][Full Text] [Related]
15. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J
Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068
[TBL] [Abstract][Full Text] [Related]
17. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
[TBL] [Abstract][Full Text] [Related]
18. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I
Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558
[TBL] [Abstract][Full Text] [Related]
19. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of prognostic factors in stage II colonic cancer.
Morris M; Platell C; de Boer B; McCaul K; Iacopetta B
Br J Surg; 2006 Jul; 93(7):866-71. PubMed ID: 16622901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
